Investment
Features
FeesSafety
Academy
More
Pluang+

Meme tokens drive 42% of Solana DEX volume as trading activity revives in 2026

Market News
27 Jul 2026
Crypto Briefing
View Source
Bullish
Meme tokens drive 42% of Solana DEX volume as trading activity revives in 2026

Meme tokens have surged back to prominence on Solana's decentralized exchanges, now accounting for about 42% of daily trading volume after a sharp decline in 2025. The Pump.fun platform, including PumpSwap, contributes nearly half of Solana's daily DEX volume, with $492 million out of $1.178 billion total. This revival was sparked by a 299% weekly surge in the ANSEM token, reigniting trader interest. Solana's low fees and fast transactions make it a hotspot for meme token speculation, with total 30-day DEX volume reaching $50.3 billion as of July 2026.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
1 hour ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
2 hours ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
3 hours ago
Aptos Labs proposes encrypted mempool to protect pending trades, adding 27ms latency if approved by governance.

Aptos Labs proposes encrypted mempool to protect pending trades, adding 27ms latency if approved by governance.

Aptos Labs has proposed an encrypted mempool feature that hides pending trade instructions until transaction ordering is complete, aiming to protect orders from frontrunning and censorship. Tests showed the feature adds 27 milliseconds of latency, ab...

Protocol Fundamentals
Bullish
4 hours ago
Pacific Booker plans $10M private placement to fund Morrison project development.

Pacific Booker plans $10M private placement to fund Morrison project development.

Pacific Booker Minerals Inc. announced a non-brokered private placement to raise up to $10 million by selling 4,273,505 units at $2.34 each. Each unit includes one common share and one warrant to buy another share at $2.75 within 36 months. The funds...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App